I n the performance of a peripheral nerve block, local anesthetic (LA) is deposited near the nerve using anatomical landmarks, often abetted by ultrasound guidance and nerve stimulator techniques. Drug molecules diffuse through the surrounding tissues to reach the peripheral nerve and interrupt nerve conduction. Deficits in sensory and motor function result when the intraneural content of LA reaches a particular level, L c , 1 and when the longitudinal spread is sufficient for a critical distance of exposure, d c . 2 Both L c and d c may be functional or anatomical characteristics of each particular class of nerve fiber. 3 After a bolus injection, the LA concentrations around the nerve vary continually, and equilibrium may not be reached at any time during a procedure. Not only is the surrounding concentration of LA changing due to tissue binding, vascular uptake, and diffusion, but also the pH varies starting from that of the typically somewhat acidic injectate, pH approximately 6.5, 4 and moving toward the normal pH, approximately 7.4, buffered by the local tissue and fluids. Further complicating the dynamics of LA distribution, the LA itself, and some of the adjuvants, including added bicarbonate:CO 2 , modify local vascular tone and thus influence the drug's removal. 5 Functional nerve blocks characterized by deficits in sensory, skeletal motor, and autonomic functions result when the blockade of conducted action potentials reaches such a degree that weakness and partial numbness occur, followed by paralysis and total anesthesia. Within the nerve, different modalities of nerve function are blocked depending on the fibers that support those functions and their conduction sensitivity to LAs. The most susceptible fibers are the small myelinated fibers, A-gamma, that account for rapid motor block, and A-delta, that obtund fast pain and cold sensation. These are followed by impulse blockade in the larger myelinated A-beta and A-alpha fibers, accounting for loss of touch and a secured motor block. Against traditional teaching, but supported by the overwhelming majority of experimental studies, the least susceptible to LA block are the small nonmyelinated C-fibers that carry slow pain and warm sensation, and among these fibers it is the slowest conducting that are the most resistant to block. 1, 6 Thus, the overall time course of functional nerve block that occurs clinically is a complicated phenomenon that depends on the pharmacodynamics and complex BACKGROUND: The potency and efficacy of local anesthetics injected clinically for peripheral nerve block depends strongly on the rate of neural drug uptake. However, because diffusion into surrounding tissues and removal by the vascular system are major factors in the overall distribution of lidocaine in vivo, true kinetics of drug/neural tissue interactions must be studied in the absence of those confounding factors. METHODS: Uptake: Ensheathed or desheathed isolated rat sciatic nerves were exposed to [ 14 C]-lidocaine for 0 to 180 minutes and then removed and the lidocaine content of nerve and sheath analyzed. Washout: Isolated nerves were soaked in [ 14 C]-lidocaine for 60 minutes and then placed in lidocaine-free solution for 0 to 30 minutes, with samples removed at different times to assess the drug content. Experimental variables included the effects of the ensheathing epineurium, lidocaine concentration, pH, presence of CO 2 -bicarbonate, and incubation duration. RESULTS: The equilibrium uptake of lidocaine increased with incubation time, concentration, and the fraction of molecules in the nonionized form. The uptake rate was unaffected by drug concentration, but was about halved by the presence of the epineurial sheath, with the washout rate slowed less. Slight alkalinization, from pH 6.8 to pH 7.4, by bicarbonate-CO 2 buffer or a nonbicarbonate buffer, enhanced the neural uptake, and to the same degree. The washout of lidocaine was faster after shorter incubations at high concentrations than when equal amounts of lidocaine were taken up after long incubations at low lidocaine concentrations. CONCLUSION: Lidocaine enters a nerve by a process other than free diffusion, through an epineurial sheath that is a slight obstacle. Given the rapid entry in vitro compared with the much smaller and transient content measured in vivo, it seems highly unlikely that lidocaine equilibrates with the nerve during a peripheral blockade. (Anesth Analg 2013;116:694-702) Section Editors: Martin Angst/Jianren Mao pharmacokinetics of LA action. Earlier studies on neurologically characterized blocks by lidocaine in rat sciatic nerve, 7 and the corresponding kinetics of lidocaine's neural distribution in vivo, 8 showed that after the minimally effective concentration of 1% (37 mM) injected as a 0.1 mL bolus, lidocaine was rapidly but inefficiently taken up; less than 5% of the injected dose actually was detected in the nerve during the block. Manipulations of the local vascular flow, with epinephrine, 9, 10 and of the solution pH and composition, 11 were able to modify the block duration and the uptake, altogether demonstrating the critical role of lidocaine's local pharmacokinetics in determining nerve block.
Because multiple factors influence these kinetics in vivo, it is desirable to conduct an in vitro study that simplifies the in vivo situation by excluding extraneural anatomical and vascular factors and permits the direct observation of neural uptake while under controlled conditions. In the isolated nerve, uptake of LA is unaffected by diffusion into adventitia, fat, and muscle. The effect of the epineurial sheath on LA distribution can be observed by comparing uptake and washout between ensheathed and desheathed nerves. The concentration of LA can be preset and remains unchanged for the duration of the experiment while the duration of incubation in LA is controlled. Composition of the bathing solution can be adjusted, and the effect of drug concentration and pH can be determined. Finally, the distribution of LA within the nerve can be implied by observing the washout of LA after different intervals of incubation.
METHODS

Nerve Preparation
Male Sprague-Dawley rats weighing 250 to 300 g were euthanized by a lethal dose of sodium pentobarbital (Nembutal, Sigma-Aldrich, St. Louis, MO, 150 mg/kg rat intraperitoneally), in a procedure approved by the Harvard Committee on Animals. Both sciatic nerves were then dissected from the hip to the ankle within 10 minutes postmortem. Both ends of the nerve as well as the side branches were ligated with silk 5 to 0 sutures to avoid uptake of lidocaine through the cut ends of nerve. The segment of nerve removed was about 30 to 35 mm long, and effort was made to use the segments with the fewest branches.
Solutions of Lidocaine
A 37 mM (1%) stock solution of lidocaine-HCl was made by dissolving 10 mg of lidocaine-HCl powder (MW 270.8, Sigma-Aldrich Chemical Co) per 1.0 mL of 154 mM (0.9%) NaCl buffered with 5 mM piperazine-N,N′-bis[2-ethanesulfonic acid] (PIPES, Sigma). The pH of this stock solution was adjusted at 22°C to 6.9 with NaOH.
Three incubation solutions of lidocaine were composed to explore the role of different factors in uptake kinetics.
1. Lidocaine solutions were prepared by diluting the stock solution into PIPES buffered saline (PBS) composed of (in millimolar): NaCl 154, PIPES 5, adjusted to pH = 6.8 to 6.9 at 37°C with NaOH. 2. To more closely approximate the in vivo conditions, when a complex ionic solution fills the interstitial space, lidocaine was diluted in Liley physiological buffer composed of (in millimolar): NaCl 118, KCl 5, 
Concentrations of Lidocaine
The lidocaine concentration bathing the nerves was initially set at 1% (37 mM), as used for published in vivo experiments in rats. 8, 9, 12, 13 However, the amount of lidocaine taken up into the nerve in vitro was so far in excess of the amount found in vivo that the lidocaine concentrations were adjusted to: 0.5 mM (0.0135%), 1 mM (0.027%), 1.9 mM (0.05%); 3.7 mM (0.1%);7.4 mM (0.2%) and 19 mM (0.5%). Radio-labeled [ 14 C]-lidocaine (DuPont-New England Nuclear, Boston, MA, 0.1 mCi/mL ethanol) 5 µL was added to 10 mL of the lidocaine solutions to give a final radiochemical activity of 5 × 10 −5 mCi/mL. This dilution results in approximately 1% of the lidocaine molecules carrying the radioctive 14 C nucleus, but these molecules are identical in chemical reactivity to those with 12 C at the same position on the molecule. The ratio of labeled to unlabeled lidocaine molecules remains the same in all experiments and, consequently, the radiolabel serves as a tag to follow the total lidocaine uptake into tissues. In the following text, the final radioactive lidocaine is abbreviated *LID.
Uptake Procedures
The sciatic nerve (composed of surrounding epineurial sheath and inner nerve fibers, perineurial barriers, and intraneural blood vessels) [14] [15] [16] [17] had its cut ends tied off, by 5-0 silk suture, to prevent *LID diffusion into the ends. Nerves were immersed in lidocaine solution for periods of 5, 10, 30, 60, and sometimes 120 and 180 minutes. At the end of the specified time, nerve was removed from the lidocaine solution, excess solution was blotted on Whatman No. 1 filter paper and the nerve frozen immediately on a small block of dry ice, preventing any redistribution of the LA. The frozen nerve was then "desheathed" by plucking off the outer, epineurium sheath with No. 6 jeweler's forceps (Roboz Surgical Instruments, Washington, DC), under a dissecting microscope at 12× magnification (Wild Heerbrugg M5, Geneva, Switzerland). The nerve and the epineurium were separately weighed (1-10 mg, Mettler Balance, Model AE 100, Fisher Scientific, Woburn, MA) and placed in a vial containing 0.1 mL double deionized water (DDW) and 0.5 mL of tissue solubilizer (Solvable R, DuPont, NEN Research Products, Boston, MA).
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Neural Kinetics of Lidocaine In Vitro Two other vials were made up and managed in the same way; 1 contained only 0.1 mL DDW and 0.5 mL Solvable to determine background radiation whereas the second vial contained, in addition, 0.1 mL of the incubating *LID, to determine the specific radioactivity of the lidocaine solution.
The tightly capped vials were then placed in a heated oven at 60°C for 90 minutes. At the end of this period, the vials were checked to confirm that the tissue had been digested. Five milliliters of liquid scintillation fluid (Aquasol 2, NEN-DuPont) was added to each vial, and radioactivity was assayed by liquid scintillation counting for 10 minutes. The radioactivity observed was assumed to represent lidocaine HCl (chromatographically determined to be 99.8% radiochemically pure by the supplier) and the derived counts per minute were divided by the total moles of added lidocaine to calculate the specific radioactivity. Intraneural content of drug was expressed as nmoles lidocaine per milligram wet weight of nerve. Efficiency of counting 14 C was the same in all conditions.
Effects of the Epineurial Sheath
The effect of the superficial sheath (epineurium) on the uptake and washout of lidocaine was measured to determine its influence on lidocaine's penetration into nerve. The ensheathed nerve was treated as described above. For the desheathed nerve, the circumferential epineurium was removed by dissecting forceps and No. 4 iridectomy scissors under 12× magnification (Wild Heerbrugg M5 dissecting microscope) before immersing the nerve in the *LID solution. The nerve, ensheathed or desheathed, was removed at specified times, and the intraneural lidocaine content was estimated as described above.
Washout Experiments
The rate at which lidocaine exited the nerve was determined in washout experiments into lidocaine-free solutions. At the end of a controlled uptake period, the sciatic nerves were placed in a large reservoir (500 mL) of drug-free Liley solution that was bubbled with 95% O 2 /5% CO 2 at 37°C for 0, 2, 5, 10, 30, or 60 minutes. At specified times, 3 to 4 nerve segments were removed, the external fluid gently blotted off on Whatman No. 1 paper and the nerve placed on dry ice, desheathed, weighed, digested, and the content of lidocaine remaining in the nerve determined by liquid scintillation counting, as for the uptake experiments.
The influence of the epineurium on washout was studied by comparing washout in ensheathed nerves, with epineurium left intact during the washout, and only removed after the nerve was taken from the washout reservoir, with washout in desheathed nerves from which the epineurium was removed before the initial uptake procedure.
In addition, the washout kinetics of lidocaine were compared after 2 nerve incubation procedures, one of long duration and the other of short duration but in a higher *LID concentration so as to achieve a similar intraneural content before washout. From the preceding uptake experiments, it was estimated that similar intraneural levels of lidocaine resulted by incubating the nerve in either *LID 1.9 mM (0.05%) for 60 minutes or in 7.4 mM (0.2%) *LID for 5 minutes, both yielding an uptake of 7 to 9 nmol/mg wet tissue.
Sciatic nerve was incubated in lidocaine 7.4 mM (0.2%) for 60 minutes.
The radioactivity of the solution in the washout reservoir was measured by placing 0.1 mL of this solution in a vial with 0.1 mL DDW and 0.5 mL Solvable and treating it identically to the other vials. These "reservoir counts" ranged from 11.3 to 20.1 cpm, not different from background (with no added radioactivity), 9.4 to 17.2 cpm, indicating that the eluted lidocaine was diluted by the washout solution to undetectably low levels.
Wet Versus Dry Weights
The intraneural content of lidocaine might be affected by the intracellular uptake or efflux of water and nerve swelling or shrinking after prolonged incubation. To test for this possibility, sciatic nerves were incubated in 37 mM lidocaine for 30, 60, 90, and 180 minutes and then desheathed and weighed wet. The desheathed nerves were then placed in a hot air oven and dried for 90 minutes and reweighed. The wet weight was compared with the dry weight for each incubation period, and the ratio was found to be not different for the various incubation times. The wet/dry ratio for 30, 60, 90, and 120 minutes, was 3.54, 3.20, 3.54, and 3.64, respectively, indicating that swelling by water uptake did not occur during the incubations.
Analysis
Data on lidocaine content were collected and averaged for each time and condition for 4 to 6 separate pieces of nerve, derived from 3 to 4 rats in each experiment. Each experimental condition was examined in 4 to 5 separate experiments (except for the washout experiment shown in Fig. 6 ); the mean ± SD for lidocaine content among these 4 to 5 independent experiments is reported here. Lidocaine nerve content, symbolized by L N , is shown as a function of *LID concentration, [*LID], after long (60 minutes) incubations, and assumed to be in equilibrium with free *LID at concentration [*LID] s . Such equilibrium data were fit by a simple binding curve with a derived maximal binding capacity (L max ) and an equilibrium dissociation constant (K L ), by Equation (1):
Uptake kinetics were determined by fitting the nerve (or sheath) content versus incubation time (t) by a single exponential function:
where L N is the nerve (or L E the sheath) content of *LID at time t, L ∞ the "equilibrium" content at infinity, and τ (tau) the uptake time constant that best fits the data. Washout kinetics were fit by a single decaying exponential function:
where L N is the neuronal content after washout time t, τ is the washout time constant, L 0 is the nerve content that is removable during the washout period, and L i is the "irreversible" (tightly bound) content that is only very slowly washed out and so remains at the end of washout. In a preliminary stage of analysis, a double exponential function was fitted, but the added variance with the additional degrees of freedom did not improve the goodness of fit so this method was not pursued. Data are graphed and fitted by the corresponding equations above, using GraphPad Prism software (San Diego, CA). Fitted parameters with their means and SDs generated by the fitting program are given in the Results section and, when appropriate, values are compared for significant differences using analysis of variance.
RESULTS
Lidocaine Uptake at Clinical Concentrations
The first experiments were conducted to simulate the conditions for the in vivo uptake of lidocaine. 8, 9, 13 The sciatic nerve with epineurial sheath intact was exposed to the "clinical" concentration of 37 mM (1%) lidocaine in buffered saline solution (pH 6.8) for up to 3 hours. At selected times, the nerve was removed and desheathed, and the sheath and nerve were separately assayed for lidocaine content. Figure 1 shows that the surrounding sheath equilibrates more rapidly than its contained nerve, although the final *LID contents are equal. The time constant for uptake by the sheath is 6.7 ± 2.7 minutes (mean ± SD) whereas that for nerve uptake is 27.4 ± 15.9 minutes (P < 0.01); the respective equilibrium uptakes (L∞) are 49.0 ± 2.9 nmoles/ mg wet for the sheath and 43.8 ± 7.2 nmoles/mg wet for the nerve (P > 0.05). Because the wet mass of epineurium equals approximately 0.45 times the mass of the desheathed nerve, it contained 30% of the "total neural" lidocaine and the nerve contained approximately 70% when equilibrium was reached.
The wet/dry mass ratio of the ensheathed nerve remained constant (3.5 ± 0.1) over 3 hours of incubation under physiological conditions, showing that neither swelling nor shrinking occurred.
Effects of the Incubating Solution Composition on Uptake
When the pH was increased to the physiological range and bubbled with CO 2 , as in the Liley solution, 1% lidocaine becomes insoluble and precipitates. 4 Therefore, in the remaining experiments, we studied much lower concentrations of lidocaine. Incubations to equilibrium (2 hours) in the physiological Liley solution, buffered with bicarbonate:CO 2 at pH = 7.4, result in a slightly smaller total but tighter affinity uptake than that for incubations in the PBS at pH = 6.8 (Fig. 2 ). Fitting these data by Equation (1) (see Methods) yields L max values of 55.9 ± 8.8 nmoles/mg wet for Liley solution and 79.8 ± 19.0 nmoles/mg wet for PBS (P < 0.05). The affinity is indicated by the inverse of the equilibrium dissociation constant, K L , which is 12.2 ± 3.8 mM for Liley and 41.6 ± 19.4 mM for PBS (P < 0.001), showing about a 3-fold higher affinity for lidocaine in the Liley solution. When the simple saline solution is buffered by bicarbonate:CO 2 , BBS, instead of PIPES, and the pH equals that of Liley solution, pH 7.4, the saturating uptake L max = 85.9 ± 62.7 nmoles/mg wet and K L = 22.0 ± 25.6 mM, differing insignificantly from the L max in PBS (P > 0.05) and significantly from that in Liley (P < 0.05), and also differing in K L values from the other 2 solutions (P < 0.01 for both). Thus, the uptake capacity of the nerve is relatively dependent on ionic composition, being lower in the more physiological solution, but is not affected by the difference in pH. The apparent affinity is greatest in the physiological solution and is least in the slightly acidic simple salt solution, a condition where more of the free lidocaine in solution is in the charged cationic rather than the neutral base form. 18 
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Concentration Independence of Uptake Kinetics
The concentration dependence of the uptake should be studied at lidocaine concentrations below saturation, that is, well below the K L values at equilibrium. Toward this end, the ensheathed nerves were incubated for times up to 1 hour in 1.85 mM (0.05%) or 7.4 mM (0.2%) lidocaine in Liley solution (Fig. 3) . The uptake kinetics were fit by a single exponential [Equation (2), see Methods] with time constant of 8.8 ± 1.5 minutes and L∞ values of 6.6 ± 0.4 nmoles/mg wet for 1.85 mM [*LID], and, τ = 9.1 ± 4.7 minutes (P > 0.05) and L∞ = 21.6 ± 3.6 nmoles/mg wet (P < 0.005) for 7.4 mM. In other words, the rate at which lidocaine was taken up by the nerve was constant and thus independent of the bathing concentration, although the final content differed and was approximately proportional to that concentration. This suggests that the rate-limiting step for uptake is not diffusion of free drug into the nerve, which would depend on concentration, but must be found in some other process.
Uptake Kinetics of Ensheathed Versus Desheathed Nerves
One candidate for the rate-limiting factor is certainly the penetration through the surrounding epineurial sheath. 14 To test this hypothesis, we examined the uptake kinetics of 0.2% (7.4 mM) lidocaine in PBS into ensheathed and desheathed nerves. The former had their epineuria removed at the end of the incubation whereas the latter were microsurgically stripped of their epineuria before the incubation began. Analysis of these uptake data, shown in Figure 4 , reports about the same equilibrium uptakes, L∞ = 21.6 ± 3.6 mg wet tissue in ensheathed nerves and 17.2 ± 2.8 mg/wet tissue (P > 0.05) in desheathed nerves. However, the uptake was about half as fast in the ensheathed nerve, with time constant 9.1 ± 4.7 minutes, than in the desheathed nerve, with time constant 5.3 ± 2.9 minutes (P < 0.02), results consistent with the epineurial sheath providing some obstacle to the entry of lidocaine into the nerve.
Influence of the Sheath on Washout Kinetics
If the circumferential sheath slows the uptake of lidocaine from the bathing solution, is it also an impediment to the removal of lidocaine from the nerve? We addressed this question by preincubating ensheathed and desheathed nerves for 60 minutes in 0.2% lidocaine dissolved in Liley solution, to load both preparations equally (Fig. 3) , and then placed the nerves in a large reservoir of drug-free Liley, removing nerve sections and assaying their *LID content at various times to measure the washout kinetics ( Fig. 5 ). For a clearer estimate of the kinetics from 4 to 5 separate experiments, each uptake was normalized to its equilibrium uptake value at zero time, just before washout began. Analysis of the averaged normalized data using Equation ( 3) (see Methods) shows a pool of drug that is rapidly washed out, L W , as a fraction of the total content (0.81 ± 0.15 in the ensheathed nerve and insignificantly larger, 0.92 ± 0.07, in the desheathed nerve [P > 0.05]). This more rapidly removable component is washed out with a somewhat slower rate from the ensheathed than the desheathed nerve (respective time constants = 8.3 ± 3.6 minutes and 5.2 ± 2.2 minutes, P < 0.05), suggesting that the rate of washout from this pool is slightly influenced by the sheath. There is an "irreversible" component of neural lidocaine that is only slowly removed during the washout period, L i , but it is only a small fraction, approximately 10%, of the total lidocaine equlibrium content. Within the limits of this method, this slow reversing fraction differs insignificantly between the 2 preparations, being 0.18 ± 0.12 in the ensheathed nerve and 0.08 ± 0.05 in the desheathed nerve.
Effect of the Loading Procedure on Washout Kinetics
In clinical use, LAs are administered as bolus injections of high concentrations and as continuously delivered solutions of lower concentration. 19, 20 We investigated the washout kinetics of lidocaine after these 2 types of exposure as a surrogate for examining the actual duration of nerve block in vivo. From the uptake kinetic studies at different lidocaine concentrations (cf. Fig. 3 and above Results), it appears that approximately the same net uptake resulted from a brief exposure to a high concentration (5 minutes in 0.2%) as that from a long exposure to a lower concentration (60 minutes in 0.05%), so these conditions were used to load separate ensheathed nerve preparations in Liley solution. However, because the uptake between the 2 conditions was not identical (the final uptake ranging from 4.6 to 6.8 nmoles/mg wet weight determined just before washout began), these "initial" values were used to normalize these starting values for each of the 3 experiments done at the 2 conditions, and the averaged normalized values for the washout calculated ( Fig. 6) . As with the other washout study, the washout kinetics were fit by the sum of a virtually constant component, L i , equal to 0.05 ± 0.06 in the rapidly loaded nerves and 0.04 ± 0.06 in the slowly loaded nerves (P > 0.05), plus a removable component fit by a single exponential function [Equation ( 3)] with identical rapidly removable fractions for the rapidly loaded, 0.94 ± 0.09, and the slowly loaded, 0.94 ± 0.07, nerves. The time constant for this component's washout was slower in the slowly loaded nerves, 12.6 ± 3.1 minutes, than in the rapidly loaded nerves, 8.3 ± 1.8 minutes (P < 0.05), showing that a long incubation at low concentrations takes longer to wash out than a fast incubation at high concentrations.
DISCUSSION
The objective of this study was to determine the kinetics of lidocaine's uptake and release by isolated peripheral nerve, for comparison with the published neuronal pharmacokinetics in vivo. The current results show that lidocaine is taken up by the nerve with a slight delay after uptake by the epineurial sheath, that the equilibrium uptake level is proportional to the drug's free concentration, until saturation occurs, but that the rate of the uptake is independent of concentration, showing that the process of neuronal uptake is not free diffusion. Equilibrium partitioning of lidocaine into nerve is greater at the slightly alkaline physiological pH of 7.4 than at the somewhat acidic pH of pharmaceutical formulations, for example, 6.5 to 6.8, consistent with the higher partitioning of the neutral base species that is favored by the higher pH. Removal of the outer, epineurial sheath speeds lidocaine's uptake into the nerve, with a smaller effect on its washout. Finally, longer incubations resulted in a slower rate of overall removal than briefer incubations, even when the concentrations were adjusted to give the same net uptake at the start of washout.
In Vivo Versus In Vitro Uptake
The neural content of lidocaine increases proportionately to its concentration in the incubation solution, up to approximately 5 to 10 mM (0.14%-0.28%), when uptake begins to saturate. In the linear range, the neural uptake corresponds to a partitioning with coefficient (slope) equal to approximately 3.5 nmoles/mg rat nerve/mM lidocaine in the bathing solution. Others have reported comparable results from studies on isolated nerve. Rosenberg et al. 21 found that ensheathed rat sciatic nerve exposed to 1 mM lidocaine took up 1.4 nmoles/mg wet nerve and Strobel and Bianchi 22 measured 1.5 nmoles/mg wet of toad sciatic nerve incubated in 0.5 mM lidocaine. Comparing the nerve mass with the volume of bathing solution gives a nerve:buffer distribution coefficient of approximately 3 to 4. 10, 21, 23 Given the relatively large hydrophobicity of lidocaine, with octanol:buffer distribution coefficient of 110 at 37°C and pH 7.4 18, 24 and high fat: buffer partition coefficient, 21 the most likely tissue location of the drug molecules is in the membranes, absorbed at the lipid aqueous interface. 25, 26 Although the conduction blocking actions of LAs occur through their binding to discrete sodium channels in the axon membranes, 27 these sites are far too sparse to be detected within the total absorption to all the bilayer membranes, for example, myelin, in the nerve. 28 
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Neural Kinetics of Lidocaine In Vitro By comparison, neural lidocaine content in sciatic nerve in vivo measured during blocking procedures is far lower. In the segment of the nerve that is closest to the locus of injection of 0.1 mL containing 1% (37 mM) lidocaine, pH = 6.8, Popitz-Bergez et al. 8 measured 8 to 10 nmoles/mg wet nerve at the time of maximal local anesthesia (motor and nociceptive block), 15 minutes after the injection. Nakamura et al. 13 detected neural contents of 1 to 6 nmoles/mg wet after in vivo blocks with 0.05 to 0.2 mL volumes (pH = 6.8), respectively, using volume-dose (mass) combinations that gave the same effective concentration, 5 to 6 mg/mL (equal to approximately 0.5%), adequate to fully block 50% of the rats, that is, a population-based EC 50 . Likewise, Sinnott et al. 9 found a peak lidocaine content in nerves taken 4 minutes after injection of 0.5% lidocaine, pH = 7.8, of 10 to 11 nmoles/mg wet, higher than the other 2 values and consistent with greater penetration of drug from the more alkaline solution. The important point here is that these values are well below the ones from equilibrium uptake of the isolated nerve in physiological conditions, 33 or 40 nmoles/mg wet at 0.5% and 1% lidocaine, respectively (Fig. 2) .
These peak in vivo uptakes correspond instead to equilibrium levels found in isolated nerve bathed in 2 to 3 mM, not the 18 to 37 mM that was injected. Further analyses show that when nociceptive responses begin to return, 30 to 40 minutes after the injection, the neural content equals approximately 2 nmoles/mg wet 9, 12 which corresponds to the in vitro content from equilibration with 1 mM lidocaine. This is also the minimum concentration of lidocaine that was required to block impulse conduction in all types of nerve fibers in vivo when the sciatic nerve was equilibrated with lidocaine solutions delivered through a nerve-encompassing perfusion chamber, 1 showing a good correspondence between the effective conditions/content for block when a bolus injection was delivered in vivo or when equilibrium could be achieved.
The current findings emphasize the inefficiency of peripheral nerve block by showing the discrepancy between the minimum effective lidocaine concentration for block in vivo, 0.5% to 1% or 18 to 37 mM 13 and the effective block in vitro,1 mM. 1 There are several reasons for this inefficiency. One is the limited mass/dose of the drug that is delivered in vivo. Unlike the virtually infinite reservoir of drug in which the nerve was equilibrated for the present in vitro experiments, functional block of rat sciatic nerve was efficiently effected at 0.1 to 0.2 mL, corresponding to a total dose of 1 to 2 mg. 13 The measured nerve:buffer distribution coefficient of 3 to 4 for lidocaine in vitro would predict that 67% to 75% of the delivered dose would equilibrate into the nerve if no other factors interfered. Instead, however, the injected solution is rapidly removed by surrounding tissues, the local circulation, and also spreads longitudinally along the nerve axis such that it is distributed along a length of approximately 3 cm of nerve, which contains only approximately 2% of the total injected dose at the time of maximum block. 8, 12, 13 
Vascular Removal
Vascular removal is an important sink for the injected LA and is a larger factor for the less hydrophobic LAs, such as lidocaine, which become less absorbed by surrounding fat, muscle, and the neural membranes per se, than for the more hydrophobic drugs such as bupivacaine. Coinjections of epinephrine (1:100,000) with lidocaine during rat nerve blocks have shown that the critical action of the vasoconstrictor in prolonging the block is at the initial uptake phase into the nerve, 9, 10 where the most intense vasoconstriction, countering the vasodilatory action of the lidocaine, 5 resulted in a larger initial loading of the LA into the nerve. 9 The measured rate of removal of lidocaine from the nerve in vivo is unaffected by the coinjection of epinephrine, probably because by the time the block regresses much of the vasoconstrictor has been removed or metabolized. 29 The limited importance of CO 2 :bicarbonate buffer. Bicarbonate has been traditionally used with LAs as an adjuvant to alkalinize the somewhat acidic pharmaceutical formulations. 4 The uptake studies here showed that weak alkalinization with bicarbonate-buffered Liley solution did enhance lidocaine's neural uptake, but no more than the same degree of alkalinization using nonbicarbonate buffer. The presence of CO 2 , at 5%, and its associated HCO 3 − , did not increase the octanol:buffer partitioning of lidocaine 24 yet CO 2 :bicarbonate buffered solutions increase the depth of epidural blockade 30 and enhance the conduction blocking actions of lidocaine on isolated peripheral nerve. 31, 32 Analysis of various LAs and of the role of pH changes per se have lead to the conclusion that CO 2 :bicarbonate acts by acidifying the cytoplasm, and favoring the more potent, charged species of intracellular LAs, and/or by altering the drug binding sites on the nerve membrane. 32 However, although such enhancement of lidocaine block has been demonstrated in isolated nerve, neurobehavioral measures of nerve block reveal that its duration is significantly shorter when lidocaine is injected in a bicarbonate buffer. 11 This shortening is probably due to the vasodilatory actions of bicarbonate on the peripheral vasculature, because it does not occur when the bicarbonate is used in an epinephrinecontaining solution.
A model for LA distribution in peripheral nerve blocks. The distribution of LAs within the peripheral nerve is key to understanding the overall time course of a nerve block. Three factors are critical for this understanding: (1) the delivered dose is rapidly removed from its injected locus by vascular removal and by uptake into surrounding tissues, of which the nerve is usually the smallest structure ( Fig. 7) ; (2) LA molecules do not diffuse freely into the nerve but are slowed slightly by the barrier of the epineurium, probably more severely by the epithelial-like perineurium, 15, 16 and partition reversibly to all of the membranous structures in the nerve, including the extensive myelin surrounding the larger nerve fibers (Fig. 7) ; and (3) during the "steady state" period of total anesthesia/numbness during clinical blockade, the LA distribution is changing within the nerve and in the surrounding structures. These factors can be best appreciated by consideration of the schematic of nerve anatomy in Figure 7 and by the hypothetical graphs of lidocaine in the 3 "compartments" shown in Figure 8 .
LA molecules partition strongly (hydrophobic adsorption) into the perineural fat and less into the more massive (and less lipoid-like) muscle surrounding the nerve. The initial uptake into these tissues, immediately after the drug solution's delivery, will rapidly deplete the free concentration of anesthetic. Drug molecules may dwell in these tissues for a long time, depending on their hydrophobicity and the intratissue vascular supply, serving as an effective buffer to release drug for neural uptake long after a bolus injection. One can appreciate that a small nerve with limited adjacent tissue and a high vascularity, such as the intraocular nerve, will have a different relationship between delivered and neurally absorbed dose than will a large nerve with massive surrounding tissues, such as the femoral nerve.
LA molecules are amphipathic, having both hydrophobic moieties and polar, and sometimes charged, hydrophilic ones. As a consequence, LAs are bound at the aqueous surface of the negatively charged lipid bilayer membranes, 25, 26 with affinities that are determined by both ionic and hydrophobic properties. 33 Passage into the nerve is not by a process of free diffusion, but rather by a dynamic series of adsorptions to and desorptions from all the membrane structures in the nerve, including passing through the epineurial structure and the more formidable and multicellular perineurium. 16, 17 This explains why the rate of anesthetic uptake is independent of the bathing concentration, because free diffusion is not the ratelimiting step for uptake. It also explains why the LA removal during washout from isolated nerve is slower after long incubations, because longer incubations allow the LA to penetrate deeper into the nerve and require that during its removal, in the absence of vascular flow, it must encounter more adsorbing membranes in its egress to the outside than if it had been more superficially adsorbed into the mantle of the nerve. Although a LA molecule must permeate the axonal plasma membrane to reach the cytoplasmic compartment of a cell and the blocking site on the sodium channel, 34 this permeation is fast compared with the slow migration through the nerve bundle by adsorption-desorption.
The reaction of LAs with the effector compartment that contains the axons of the nerve is correctly considered as a rate competition reaction. Uptake into adjacent tissue and removal by vasculature rapidly deplete the supply of delivered dose and compete with the nerve for the free LA molecules. The resulting neural content is remarkably transient, reaching its peak value early after injection and then slowly declining as drug is removed by the vasculature while it is also being slowly released from the adjacent tissues, even during an apparently constant nerve block. The overall duration of an effective block, during which the neural content exceeds the critical content for conduction block (given an adequate length of drug exposed nerve), 2 is largely dependent not only on the initial loading into the nerve but also on the ability of the adjacent tissues to "buffer" the neural concentration, as shown by the parallel slow decay of L T and L N ( Fig. 8 ). Of course, if the initial delivery is too far from the nerve, no release from the adjacent tissues can result in a clinically effective neural content, regardless of the pharmacological manipulation of kinetic factors. Figure 8 . Theoretical curves describe the kinetics of lidocaine's distribution during a nerve block in vivo. Lidocaine is injected, in an ideal situation, immediately adjacent to the nerve in a solution with concentration L s which decreases rapidly. The tissues surrounding the nerve take up lidocaine, L T , as it diffuses from the injected solution, and then more slowly release it, providing a reservoir that delivers drug for an extended period of time. Lidocaine in the nerve, L N , is taken up rapidly from the injected solution and then is removed with fast and slow decay phases, the fast phase from the intraneural vascular removal and the uptake back into adjacent tissues, and the slow phase from the exchange from the high-capacity adjacent tissues. Effective conduction block occurs when L N exceeds the critical blocking content, L C . Figure 7 . A schematic of the sciatic nerve (N) showing fascicles of myelinated and nonmyelinated nerve fibers encased in the perineurium, a structure composed of tightly connected epithelial cells. The perineuria and the inner endoneurium of connective tissue are all enclosed by the epineurium. Blood vessels (V) course inside and outside the nerve and in the adjacent tissue (T), which is typically much more massive than the nerve. Injected solutions of local anesthetic (L s ) surround the nerve from which drug is taken up by it and by the adjacent tissue (fat and muscle) and removed by the vasculature.
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Neural Kinetics of Lidocaine In Vitro In summary, peripheral nerve block by LAs is a highly inefficient process due to the rate competition nature of the drug distribution. There is no way to change the anatomical organization around the peripheral nerve, but block efficiency can be improved by increasing the membranepenetrating species by neutralizing, or slightly alkalinizing the solution, by the use of vasoconstrictors, and by applying the drug as close as is safely possible to the target nerve. Although we knew all this from clinical practice, the present paper provides a theoretical framework for its integrated understanding. E DISCLOSURES Name: Stanley Leeson, MB. Contribution: This author helped conduct the experiments, analyze the data, and write the manuscript.
